Novavax announces extension of contract with HHS-BARDA
The contract was originally awarded in February 2011, with funding of up to $97m over an initial base period ending in February 2014. Novavax and BARDA have agreed
Boehringer Ingelheim has signed a research collaboration agreement with Combotope Therapeutics to advance tumour-selective antibody therapies targeting cancer.
Combination of Empiriko’s chemosynthetic livers and Interchim’s innovative instrumentation and expertise in the field of liquid chromatography allows pharmaceutical scientists to predict metabolism patterns, pathways and profiles, while
A second NOA has been received for US Patent Application Serial No. 11/782,838 entitled ‘Controlled-release pharmaceutical tablets’ which is related to the drug delivery technology used in Forfivo
The call for proposals comes after newly released recommendations from the Society for Healthcare Epidemiology of America (SHEA) shed light on the issue of contaminated healthcare personnel apparel